Possis bids to restore AngioJet elevation
This article was originally published in The Gray Sheet
Executive Summary
Retrospective registry data on the vascular thrombectomy system will be presented at the American College of Cardiology Annual Scientific Session in Orlando, Fla. March 6-9, the company says Feb. 22. Possis Medical attributes a drop in AngioJet sales to the September 2004 release of AiMI clinical trial results, which showed a failure of the device to reduce the size of myocardial infarctions (1"The Gray Sheet" Aug. 30, 2004, p. 9). For Q2 FY 2005 (ended Jan. 31), AngioJet sales dipped 8% year-over-year - and 7% sequentially - to $15.6 mil., Possis reports...